To include your compound in the COVID-19 Resource Center, submit it here.

Takeda, AZ partner to develop PD candidate

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) partnered with AstraZeneca plc (LSE:AZN; NYSE:AZN) to co-develop MEDI1341, a preclinical AZ

Read the full 177 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE